Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP
In Brief: Durant Says He Expects Comprehensive Centers Lineup to Change With New System
Suitable Mechanism, Funding Source Were Issues In diet FIT
Final Issue Of Decade; Office Closed, But Not Phone Or Fax
Minority CCOP Applications Not Yet Reviewed
Joint NCI/FDA Program approved; ‘May Solve Our Differences’
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
